Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
B02AA
|
| gptkbp:contraindication |
hypersensitivity
active intravascular clotting |
| gptkbp:discoveredIn |
20th century
|
| https://www.w3.org/2000/01/rdf-schema#label |
antifibrinolytic drugs
|
| gptkbp:includes |
gptkb:tranexamic_acid
gptkb:aprotinin aminocaproic acid |
| gptkbp:indication |
hemophilia
cardiac surgery menorrhagia dental procedures |
| gptkbp:mechanismOfAction |
inhibit fibrinolysis
|
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
vomiting thromboembolic events |
| gptkbp:usedFor |
prevention of excessive bleeding
|
| gptkbp:bfsParent |
gptkb:von_Willebrand_disease
|
| gptkbp:bfsLayer |
6
|